October 2022 | New Models & Highlights
Upcoming Events
Date: October 27th, 2022
Meet us at booth #13 to learn more about our capabilities to support your research needs from concept to therapeutic discovery.
Date: September 29th, 2022
Learn more about our platforms suited for antibody discovery services.
Dates: November 2nd - 4th, 2022
Stop by our booth to learn how we can streamline therapeutic antibody discovery for all targets.
Press Releases
Biocytogen to Present Progress of Preclinical and Clinical Assets at BIO-EUROPE 2022
Biocytogen will present pipeline assets and the progress of Project Integrum at the upcoming BIO-EUROPE conference in Leipzig, Germany from October 24th through the 26th.
Biocytogen and Eucure Biopharma License OX40 Antibody (YH002) to Syncromune to Develop and Commercialize Intratumoral Immunotherapy
Under the terms of the agreement, Syncromune will acquire exclusive worldwide rights for development and commercialization of the intratumoral combination therapy containing Eucure’s YH002, and multiple other active ingredients as part of the SyncrovaxTM therapy.